Kindbody has announced its appointment of Dean Morbeck as its first chief scientific officer. Morbeck brings 25 years of experience researching in vitro fertilization (IVF).
“We are thrilled to add an experienced scientist like Dean to help further our mission of using data-driven research to deliver exceptional care,” Annbeth Eschbach, president of Kindbody, said in a statement. “Dean has a wealth of experience in this field and is passionate about delivering the highest quality care to patients. We have no doubt that under his leadership, Kindbody will continue to provide outstanding results to our patients.”
